Lymphoma News and Research

RSS
Lymphoma is cancer that begins in cells of the immune system. There are two basic categories of lymphomas. One kind is Hodgkin lymphoma, which is marked by the presence of a type of cell called the Reed-Sternberg cell. The other category is non-Hodgkin lymphomas, which includes a large, diverse group of cancers of immune system cells. Non-Hodgkin lymphomas can be further divided into cancers that have an indolent (slow-growing) course and those that have an aggressive (fast-growing) course. These subtypes behave and respond to treatment differently. Both Hodgkin and non-Hodgkin lymphomas can occur in children and adults, and prognosis and treatment depend on the stage and the type of cancer.
New study sheds light on how CAR T cell therapy works

New study sheds light on how CAR T cell therapy works

Mutant p53 protein 'tackles' DNA guardian to drive tumor development

Mutant p53 protein 'tackles' DNA guardian to drive tumor development

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

TGen and City of Hope announce letter of intent to develop new cell therapy manufacturing facility

TGen and City of Hope announce letter of intent to develop new cell therapy manufacturing facility

Amgen announces presentation of new clinical data showcasing early oncology pipeline at ASH 2018

Amgen announces presentation of new clinical data showcasing early oncology pipeline at ASH 2018

TGen, City of Hope to develop cell therapy manufacturing facility in Phoenix

TGen, City of Hope to develop cell therapy manufacturing facility in Phoenix

UCLA researchers investigate how a protein factor contributes to cancer cell migration

UCLA researchers investigate how a protein factor contributes to cancer cell migration

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Cytokine levels could predict autoimmune reactions to cancer immunotherapy

Cytokine levels could predict autoimmune reactions to cancer immunotherapy

3 Harvard scientists receive Allen awards for work in neuroimmunology, developmental biology, cancer

3 Harvard scientists receive Allen awards for work in neuroimmunology, developmental biology, cancer

Study shows how machinery within immune system activates T cells to attack cancer

Study shows how machinery within immune system activates T cells to attack cancer

Scientists pinpoint TIM-3 protein as next potential target for immunotherapy treatments

Scientists pinpoint TIM-3 protein as next potential target for immunotherapy treatments

Ten Allen Distinguished Investigators for 2018 announced by Paul G. Allen Frontiers Group

Ten Allen Distinguished Investigators for 2018 announced by Paul G. Allen Frontiers Group

New approach may lead to protective vaccines for immunocompromised patients

New approach may lead to protective vaccines for immunocompromised patients

Head and neck cancer survivors more likely to commit suicide

Head and neck cancer survivors more likely to commit suicide

Scientists identify new target for battling deadly form of leukemia

Scientists identify new target for battling deadly form of leukemia

MIT researchers devise way to help blood cells regenerate after radiation therapy

MIT researchers devise way to help blood cells regenerate after radiation therapy

NCI grant awarded to Abramson Cancer Center to study CAR T cells In solid tumors

NCI grant awarded to Abramson Cancer Center to study CAR T cells In solid tumors

Organic food may protect against cancers finds study

Organic food may protect against cancers finds study

Study findings could set new standard of care for advanced anal cancer

Study findings could set new standard of care for advanced anal cancer